Open Access
Rapid Quantitative Evaluation of CRISPR Genome Editing by TIDE and TIDER
Тип публикации: Book Chapter
Дата публикации: 2019-03-25
SCImago Q4
БС3
SJR: 0.423
CiteScore: 2.2
Impact factor: —
ISSN: 10643745, 19406029
PubMed ID:
30912038
Краткое описание
Current genome editing tools enable targeted mutagenesis of selected DNA sequences in many species. However, the efficiency and the type of introduced mutations by the genome editing method are largely dependent on the target site. As a consequence, the outcome of the editing operation is difficult to predict. Therefore, a quick assay to quantify the frequency of mutations is vital for a proper assessment of genome editing actions. We developed two methods that are rapid, cost-effective, and readily applicable: (1) TIDE, which can accurately identify and quantify insertions and deletions (indels) that arise after introduction of double strand breaks (DSBs); (2) TIDER, which is suited for template-mediated editing events including point mutations. Both methods only require a set of PCR reactions and standard Sanger sequencing runs. The sequence traces are analyzed by the TIDE or TIDER algorithm (available at
https://tide.nki.nl
or
https://deskgen.com
). The routine is easy, fast, and provides much more detailed information than current enzyme-based assays. TIDE and TIDER accelerate testing and designing of DSB-based genome editing strategies.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Для доступа к списку цитирований публикации необходимо авторизоваться.
Для доступа к списку профилей, цитирующих публикацию, необходимо авторизоваться.
Топ-30
Журналы
|
5
10
15
20
25
30
35
|
|
|
bioRxiv
33 публикации, 22%
|
|
|
Nature Communications
8 публикаций, 5.33%
|
|
|
The CRISPR Journal
4 публикации, 2.67%
|
|
|
Scientific Reports
4 публикации, 2.67%
|
|
|
International Journal of Molecular Sciences
3 публикации, 2%
|
|
|
Plants
3 публикации, 2%
|
|
|
Communications Biology
3 публикации, 2%
|
|
|
Cancers
2 публикации, 1.33%
|
|
|
Frontiers in Genetics
2 публикации, 1.33%
|
|
|
Developmental Biology
2 публикации, 1.33%
|
|
|
STAR Protocols
2 публикации, 1.33%
|
|
|
Molecular Therapy - Methods and Clinical Development
2 публикации, 1.33%
|
|
|
Biotechnology Journal
2 публикации, 1.33%
|
|
|
Molecular Oncology
2 публикации, 1.33%
|
|
|
Frontiers in Plant Science
2 публикации, 1.33%
|
|
|
PLoS Biology
2 публикации, 1.33%
|
|
|
Journal of Biological Chemistry
2 публикации, 1.33%
|
|
|
Molecular Cell
2 публикации, 1.33%
|
|
|
Discover Oncology
2 публикации, 1.33%
|
|
|
Cell Reports
2 публикации, 1.33%
|
|
|
Molecular Therapy Advances
2 публикации, 1.33%
|
|
|
Signal Transduction and Targeted Therapy
1 публикация, 0.67%
|
|
|
DMM Disease Models and Mechanisms
1 публикация, 0.67%
|
|
|
Human Gene Therapy
1 публикация, 0.67%
|
|
|
Frontiers in Immunology
1 публикация, 0.67%
|
|
|
Frontiers in Allergy
1 публикация, 0.67%
|
|
|
Nature Genetics
1 публикация, 0.67%
|
|
|
Cell and Bioscience
1 публикация, 0.67%
|
|
|
Parasites and Vectors
1 публикация, 0.67%
|
|
|
Gene
1 публикация, 0.67%
|
|
|
5
10
15
20
25
30
35
|
Издатели
|
5
10
15
20
25
30
35
|
|
|
openRxiv
34 публикации, 22.67%
|
|
|
Springer Nature
33 публикации, 22%
|
|
|
Elsevier
31 публикация, 20.67%
|
|
|
MDPI
10 публикаций, 6.67%
|
|
|
Wiley
10 публикаций, 6.67%
|
|
|
Frontiers Media S.A.
6 публикаций, 4%
|
|
|
Mary Ann Liebert
5 публикаций, 3.33%
|
|
|
Public Library of Science (PLoS)
3 публикации, 2%
|
|
|
The Company of Biologists
2 публикации, 1.33%
|
|
|
Taylor & Francis
2 публикации, 1.33%
|
|
|
Oxford University Press
2 публикации, 1.33%
|
|
|
American Society of Nephrology
1 публикация, 0.67%
|
|
|
eLife Sciences Publications
1 публикация, 0.67%
|
|
|
International Society for Horticultural Science (ISHS)
1 публикация, 0.67%
|
|
|
American Chemical Society (ACS)
1 публикация, 0.67%
|
|
|
Proceedings of the National Academy of Sciences (PNAS)
1 публикация, 0.67%
|
|
|
American Society of Hematology
1 публикация, 0.67%
|
|
|
Allerton Press
1 публикация, 0.67%
|
|
|
Royal Society of Chemistry (RSC)
1 публикация, 0.67%
|
|
|
American Association for the Advancement of Science (AAAS)
1 публикация, 0.67%
|
|
|
American Association for Cancer Research (AACR)
1 публикация, 0.67%
|
|
|
Publishing House Belorusskaya Nauka
1 публикация, 0.67%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 публикация, 0.67%
|
|
|
5
10
15
20
25
30
35
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.
Вы ученый?
Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Войти с ORCID
Метрики
150
Всего цитирований:
150
Цитирований c 2025:
49
(32.66%)
Цитировать
ГОСТ |
RIS |
BibTex
Цитировать
ГОСТ
Скопировать
Brinkman E. K., van Steensel B. Rapid Quantitative Evaluation of CRISPR Genome Editing by TIDE and TIDER // Methods in Molecular Biology. 2019. Vol. 1961. pp. 29-44.
ГОСТ со всеми авторами (до 50)
Скопировать
Brinkman E. K., van Steensel B. Rapid Quantitative Evaluation of CRISPR Genome Editing by TIDE and TIDER // Methods in Molecular Biology. 2019. Vol. 1961. pp. 29-44.
Цитировать
RIS
Скопировать
TY - GENERIC
DO - 10.1007/978-1-4939-9170-9_3
UR - https://doi.org/10.1007/978-1-4939-9170-9_3
TI - Rapid Quantitative Evaluation of CRISPR Genome Editing by TIDE and TIDER
T2 - Methods in Molecular Biology
AU - Brinkman, Eva Karina
AU - van Steensel, Bas
PY - 2019
DA - 2019/03/25
PB - Springer Nature
SP - 29-44
VL - 1961
PMID - 30912038
SN - 1064-3745
SN - 1940-6029
ER -
Цитировать
BibTex (до 50 авторов)
Скопировать
@incollection{2019_Brinkman,
author = {Eva Karina Brinkman and Bas van Steensel},
title = {Rapid Quantitative Evaluation of CRISPR Genome Editing by TIDE and TIDER},
publisher = {Springer Nature},
year = {2019},
volume = {1961},
pages = {29--44},
month = {mar}
}
Ошибка в публикации?